AI Sharpens Pathologists' Interpretation of Tissue Samples

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately. This is shown by a study led by Karolinska Institutet, conducted in collaboration with researchers from Yale University.

It is already known that tumour-infiltrating lymphocytes (TILs) are an important biomarker in several cancers, including malignant melanoma (skin cancer). TILs are immune cells found in or near the tumour, where they influence the body's response to the cancer. In malignant melanoma, the presence of TILs plays a role in both diagnosis and prognosis, with a high presence being favourable. An important part of pathologists' work in malignant melanoma is to estimate the amount of TILs. Researchers at Karolinska Institutet have now investigated how pathological assessments were affected by an AI tool trained to quantify TILs.

The study included 98 pathologists and researchers from other professions divided into two groups. One group consisted solely of experienced pathologists. They worked ‘as usual’, i.e. they looked at digital images of stained tissue sections and estimated the amount of TILs according to current guidelines. The second group included pathologists, but also researchers from other professions - all of whom had some experience in assessing pathological images. They also looked at the images ‘as usual,’ but were assisted by AI support that quantified the amount of TILs. Everyone assessed 60 tissue sections, all from patients with malignant melanoma. The study was retrospective, so the images showed tissue samples from patients whose diagnosis and treatment had already been determined.

The assessments made with AI support were superior to the others in several ways. Among other things, reproducibility was very high – the results were very similar regardless of who performed the review. This is important because assessments of TILs can currently vary depending on who performs them, which can compromise medical safety. The AI-supported assessments also provided a more accurate picture of the patients' disease prognoses – since the study was retrospective, there was a ‘correct answer’ to compare with. However, this outcome was unknown to those who assessed the images.

"Understanding the severity of a patient's disease based on tissue samples is important, among other things, for determining how aggressively it should be treated. We now have an AI-based tool that can quantify the TIL biomarker, which could help with treatment decisions in the future. However, more studies are needed before this AI tool can be used in clinical practice, but the results so far are promising and suggest that it could be a very useful tool in clinical pathology," says the study's last author, Balazs Acs, associate professor at the Department of Oncology-Pathology at Karolinska Institutet and a clinically active pathologist.

Aung TN, Liu M, Su D, et al.
Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma.
JAMA Netw Open. 2025;8(7):e2518906. doi: 10.1001/jamanetworkopen.2025.18906

Most Popular Now

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Accurately Classifies Pancreatic Cyst…

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the Magnetic Resonance Imaging...

Free AI Tools can Help Doctors Read Medi…

A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more...

Autonomous AI Agents in Healthcare

The use of large language models (LLMs) and other forms of generative AI (GenAI) in healthcare has surged in recent years, and many of these technologies are already applied in...

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...